Nicolas Tilmans

@ntilmans

Founder/CEO Anagenex working at edge of biochemistry+tech

Vrijeme pridruživanja: ožujak 2010.

Tweetovi

Blokirali ste korisnika/cu @ntilmans

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ntilmans

  1. prije 7 sati

    This cancer "atlas" in nature offers some hope that we could eventually fully treat cancer. What if we had selective drugs to a large fraction of the driver pathways? We've got our work cut out for us!

    Poništi
  2. 17. sij

    To an EHR you're a source of revenue, a datapoint they can monetize. It's your data, you should own it, you should have a system that makes it easy to share, interpret and MOST importantly easily keep it safe.

    Poništi
  3. 16. sij

    Awesome paper from and her lab showing a new mechanism for neuron differentiation linked to calcium

    Poništi
  4. 16. sij

    Great presentation by showing how is forging a new path in drug discovery.

    Poništi
  5. 15. sij

    Today I'll be joining join () and () to hear their thoughts on ML+Drug Discovery and talk about what we're building at . Join here thanks to host .

    Poništi
  6. 14. sij

    Such an important thing to get right, sad to see it not get solved. We still need innovative ways to identify and track disease, especially if we hope to better understand how human disease (and not mouse disease) work.

    Poništi
  7. 9. sij

    Awesome team and mission, congrats to and on this big step!

    Poništi
  8. proslijedio/la je Tweet
    9. sij

    Here is who we are, our mission, vision, and goals. "Introducing Variant Bio" - our blog is now live.

    Poništi
  9. 9. sij

    Really cool paper, we are working to apply these sorts of tools in new ways anchored in real-world high throughput biochemistry.

    Poništi
  10. 9. sij
    Poništi
  11. 9. sij
    Prikaži ovu nit
    Poništi
  12. 8. sij

    Excited to join and to hear their thoughts on ML+Drug Discovery and talk about what we're building at ! Thank you to for hosting!

    Prikaži ovu nit
    Poništi
  13. 8. sij

    Good first step on ethics in pharma, but then at the end: "The signatures above do not necessarily reflect the policies or positions of the agencies, organizations, employers, or companies with which the signers are affiliated." via

    Poništi
  14. 8. sij
    Poništi
  15. 13. pro 2019.
    Poništi
  16. proslijedio/la je Tweet
    13. pro 2019.

    Congrats to SW on his paper published in ACS Chem Bio! Dedicated to Prof. LLK! @KiesslingLab

    Poništi
  17. 3. pro 2019.

    Well done and well deserved and Ben, amazing company!

    Tweet je nedostupan.
    Poništi
  18. proslijedio/la je Tweet
    27. stu 2019.

    AI is fundamentally changing the process of scientific discovery. 🧪🧬 In his Babbage podcast, of goes deep on the subject. Episode features , , of , of & of

    Poništi
  19. 7. stu 2019.

    Heartbreaking story at the highest levels of sport. No person should have to go through this sort of abuse.

    Poništi
  20. proslijedio/la je Tweet

    Did you know: if you ever find a scientific article that you’d like to read, but it’s behind a paywall - you can just email the author(s) to request a copy? Most researchers are super happy to send you a PDF - we’re eager to share our work, and are happy that you’re interested!

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·